Our analysis of lymph nodes from TB cases and the results of our in vitro experiments support the hypothesis that carriers of the two-locus genotype MCP-1 GG MMP-1 2G/2G are at increased risk for progression to active TB because they express a unique phenotype characterized by high levels of both MCP-1 and free MMP-1. This evidence concerns the gene CCL2 and tuberculosis.